Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 17, 2021

Thermo Fisher Scientific receives EUA for Covid-19 combo kit

Thermo Fisher Scientific has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its multiplex real-time PCR test, Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit.

Thermo Fisher Scientific has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its multiplex real-time PCR test, Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit.

The kit is used for identifying and distinguishing RNA from the SARS-CoV2, and influenza A and B viruses in nasopharyngeal and nasal swabs.

Thermo Fisher Scientific Genetic Sciences president Mark Smedley said: “Understanding that the flu season would overlap with surges in Covid-19 infections, Thermo Fisher worked rapidly to develop a new multiplex real-time PCR diagnostic kit for detecting and differentiating SARS-CoV-2, influenza A, and influenza B.

“These are illnesses, which can present with similar clinical symptoms, but for which patient management, including quarantining measures, greatly differs.

“This new kit offers clinical and public health laboratories a single test to help diagnose and monitor the spread of Covid-19 and the flu.”

Apart from aiding laboratories in increasing their present Covid-19 testing menu for respiratory samples, the kit will help maintain low operational costs and simple workflow.

Content from our partners
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
“This technique means everything to us”: How CGM devices empower users 

Furthermore, the TaqPath COVID-19, Flu A, Flu B Combo Kit includes Applied Biosystems Pathogen Interpretive Software for automatically converting genetic analysis data into a readable report. This will lower the chances of user interpretation error.

Thermo Fisher noted that testing with the kit is limited to Clinical Laboratory Improvement Amendments of 1988 (CLIA) certified laboratories for carrying out high-complexity tests or by non-US labs with similar qualifications.

Last December, the company introduced a new direct-from-saliva PCR test for Covid-19 to support extensive, high-frequency surveillance testing.

The Applied Biosystems TaqCheck SARS-CoV-2 Fast PCR Assay uses raw saliva samples to streamline lab workflows with the help of tools available worldwide to provide reliable data rapidly.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU